NCT02742298View on ClinicalTrials.gov

Pompe Disease QMUS and EIM

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 24, 2016

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
Pompe Disease
Interventions
DEVICE

Muscle ultrasound

Ultrasound images of limb muscles will be collected.

OTHER

Electrical Impedance Myography

A painless current passes through the skin and surface electrodes are used to record the impedance through muscle.

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

Genzyme, a Sanofi Company

INDUSTRY

lead

Duke University

OTHER

NCT02742298 - Pompe Disease QMUS and EIM | Biotech Hunter | Biotech Hunter